Innovatus Life Sciences Lending Fund I, LP — Form D
Innovatus Life Sciences Lending Fund I, LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2017-03-17. Industry: Pooled Investment Fund.
Offering
- Filed: 2017-03-17
- Form: D
- Accession: 0000943663-17-000106
- Industry: Pooled Investment Fund
- Exemptions: 3C, 3C.7
- Minimum investment: $5.0M
- Security types: fund interests
- SEC file number: 021-282837
Issuer
- Name: Innovatus Life Sciences Lending Fund I, LP
- CIK: 0001692825
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 777 THIRD AVENUE, NEW YORK, NY, 10017
- Phone: 212.698.4595
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Andrew Dym | Executive Officer | New York, NY |
| David Schiff | Executive Officer | New York, NY |
| N/A Innovatus Capital Partners, LLC | Promoter | New York, NY |
| Andrew Hobson | Executive Officer | New York, NY |
| Sean Wilke | Executive Officer | New York, NY |
| N/A Innovatus Flagship Parent GP, LLC | Executive Officer | New York, NY |
| N/A Innovatus Life Sciences GP, LP | Executive Officer | New York, NY |
| Joseph Schottland | Executive Officer | New York, NY |
Other filings by this issuer (8)
More